Ephrin receptor A10 is a promising drug target potentially useful for breast cancers including triple negative breast cancers-Reference-Cited by-同舟云学术

Ephrin receptor A10 is a promising drug target potentially useful for breast cancers including triple negative breast cancers

Published:2014-09 Issue: Volume:189 Page:72-79
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Nagano Kazuya,Maeda Yuka,Kanasaki So-ichiro,Watanabe Takanobu,Yamashita Takuya,Inoue Masaki,Higashisaka Kazuma,Yoshioka Yasuo,Abe Yasuhiro,Mukai Yohei,Kamada Haruhiko,Tsutsumi Yasuo,Tsunoda Shin-ichi

Funder

Ministry of Education, Culture, Sports, Science and Technology of Japan

Japan Society for the Promotion of Science

Ministry of Health, Labor and Welfare of Japan.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference43 articles.

1. Molecular therapy of breast cancer: progress and future directions;Lin;Nat. Rev. Endocrinol.,2010

2. Trastuzumab and antiestrogen therapy: focus on mechanisms of action and resistance;Ocana;Am. J. Clin. Oncol.,2006

3. Triple-negative breast cancer: disease entity or title of convenience?;Carey;Nat. Rev. Clin. Oncol.,2010

4. Triple negative breast cancer: unmet medical needs;Pal;Breast Cancer Res. Treat.,2011

5. Triple-negative breast cancer: present challenges and new perspectives;Podo;Mol. Oncol.,2010

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling Biomarker Signatures in Triple-Negative Breast Cancer: A Systematic Review for Targeted Approaches;International Journal of Molecular Sciences;2024-02-22

2. Eph receptors and ephrins in cancer progression;Nature Reviews Cancer;2023-11-23

3. Advances in immunotherapy for triple-negative breast cancer;Molecular Cancer;2023-09-02

4. Eph Receptors in Cancer;Biomedicines;2023-01-23

5. Transcriptomic Analysis of Subtype-Specific Tyrosine Kinases as Triple Negative Breast Cancer Biomarkers;Cancers;2023-01-07